D-0334-2026 Class II Ongoing

Recalled by Fresenius Kabi Compounding, LLC — Canton, MA

FDA drug recall D-0334-2026 was initiated by Fresenius Kabi Compounding, LLC on Feb 5, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 1410 bags.

Recall details

Product Type
Drugs
Report Date
Feb 18, 2026
Initiation Date
Feb 5, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1410 bags

Product description

ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-050-56

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

US Nationwide.

Code information

Lot # C274-000047883, Exp Date: 17-Feb-26; Lot # C274-000048515, Exp Date: 22-Mar-26; Lot # C274-000048679, Exp Date: 31-Mar-26; Lot # C274-000049119, Exp Date: 19-Apr-26; Lot # C274-000049282, Exp Date: 27-Apr-26

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0334-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0334-2026. Report a data issue: hello@regdatalab.com.